Abstrato

Artificial Intelligence: Microchip Based Drug Delivery Through Resealed Erythrocytes

Rode A, Sharma S, Hatware K

In present scenario, the Artificial Intelligence in performing sophisticated tasks and computations has gradually led it to be introduced to solve many problems for betterment of a patients. Cellular carriers possess a great potential in various modules of drug delivery. Among such cellular carriers, erythrocytes have been found to possess huge merits for the targeted and controlled drug delivery system and could be manipulated with reference to time. Introduction of a wireless microchips in some of resealed erythrocytes can be thought to target the thrombus. In several cases, post-operative formation of a repeated thrombus is a common problem. If we target those thrombi by loading the antithrombotic drug with biosensor or by video monitoring, as like of an angioplasty, higher therapeutic success can be achieved. If same can be done by inserting wireless microchip with camera and biosensor so that when erythrocytes pass from the thrombus, it will give some indication to controlling device which will break or burst the erythrocytes over thrombus which contains the antithrombotic agents so that clot will dissolve and this can be monitored by wireless devices. This may helpful to prevent various blockages occurring due to clots, which otherwise lead to strokes or other life threatening complications. It is hypothesis that we can use these devices and can prevent the stroke which may lead to further complications. This assumption if made possible, it will provide better compliance to the patients.